MITTR  |  Biotechnology and health

Mind-altering substances are (still) falling short in clinical trials

精神改变物质在临床试验中(仍然)未能达到预期效果

Mind-altering substances are (still) falling short in clinical trials
2026-03-20  1171  困难
字体

Two studies out earlier this week demonstrate just how difficult it is to study these drugs. And to my mind, they also show just how overhyped these substances have become.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。